IP Verse

Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody

Patent No. EP3806891 (titled "Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody") was filed by Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Jun 14, 2019. The application was issued on Aug 2, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANApr 30, 2024VOSSIUS & PARTNER
STRAWMANApr 30, 2024VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3806891

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP19742443A
Filing Date
Jun 14, 2019
Status
Granted And Under Opposition
Jun 30, 2023
Publication Date
Aug 2, 2023
External Links
Slate, Register , Google Patents